Reach Pharmaceuticals logo — Reach Pharmaceuticals

Reach Pharmaceuticals

Reach Pharmaceuticals

Founded 2020 Australia Preston, Australia 4 employees Manufacturing, Pharmaceutical

General Information

Company Name Reach Pharmaceuticals
Founded Year 2020
Location Australia Preston, Australia +1
Employees 4
Industries Manufacturing, Pharmaceutical
Social

Get notified when Reach Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Reach Pharmaceuticals

Reach Pharmaceuticals is an Australian privately-owned pharmaceutical company established in 2018 with a focus on marketing innovative products with a first-to-market advantage. The company also registers and supplies complex generics and other therapeutic goods based on demand from clinicians. Their pipeline includes thiotepa, potassium citrate, isoprenaline, icatibant, urokinase, carboprost, and romidepsin, among others. Reach Pharmaceuticals has the capabilities to pursue compassionate supplies of products to fulfill shortages and manage the entire process from product identification to sales generation. The company is a leader in the hospital pharmaceuticals space and holds the majority market share for all the products launched to date, whether registered or supplied under compassionate supplies. Additionally, Reach Pharmaceuticals has an interest in the distribution of branded products and has plans to launch new products in the future. The headquarters of Reach Pharmaceuticals is located in Australia. As of now, there is no available information on the last investment or the investors involved. With a strong focus on innovative pharmaceutical products and a significant presence in the hospital pharmaceuticals market, Reach Pharmaceuticals presents an interesting opportunity for potential investors seeking to participate in the pharmaceutical industry.

Taxonomy: pharmaceuticals, Australian company, innovative products, first to market advantage, complex generics, therapeutic goods, drug distribution, hospital pharmaceuticals, compassionate supplies, market leader, product registration, branded products, market analysis

No funding data available for Reach Pharmaceuticals yet.

Get notified when Reach Pharmaceuticals raises funding

Reach Pharmaceuticals Alternatives & Competitors

Reach Pharmaceuticals vs

Engagement Matters

20 employees
Health Care, Hospitality
Reach Pharmaceuticals vs

Develop, manufacture and bring to market high-quality, difficult to formulate, solid oral pharmaceut...

39 employees
Manufacturing, Pharmaceutical
Reach Pharmaceuticals vs
R & S Northeast
R & S Northeast United States

R&S Northeast, LLC has operated as a national pharmaceutical wholesaler since 1973.

78 employees
Biotechnology

FAQ About Reach Pharmaceuticals

Reach Pharmaceuticals
Reach Pharmaceuticals was founded in 2020.
Reach Pharmaceuticals is headquartered in Preston, Australia.
Reach Pharmaceuticals operates in the following industries: Manufacturing, Pharmaceutical.
Reach Pharmaceuticals has approximately 4 employees.
Top alternatives and competitors to Reach Pharmaceuticals include Gothia Medical AB, i3 Pharmaceuticals, LLC, R & S Northeast, Sigma Pharmaceuticals, LLC, Sauflon CL Kft.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Reach Pharmaceuticals and Gothia Medical AB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Reach Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes